References
- Wallach J. Cardiovascular diseases. Interpretation of diagnostic tests6th ed, J Wallach. Little, Brown Co., Boston 1996; 120
- Kaplan MM. Alkaline phosphatase. Gastroenterology 1972; 62: 452–68
- Goldberg DM. Structural, functional and clinical aspects of gamma-glutamyl transferase. Crit Rev Clin Lab Sci 1980; 12: 1–58
- Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38: 263–355
- Yamashita M, Sasaki M, Mii K, Tsuzuki M, Takakura K, Yoshinoya S, et al. Measurement of serum alkaline phoshatase isozyme I in brain-damaged patients. Neurol Med Chir 1989; 29: 995–8
- Nand N, Gupta S, Sharma M, Khosla SN, Saini AS. Evaluation of enzymes in serum and cerebrospinal fluid in cases of cerebrovascular accidents. Angiology 1987; 38: 750–5
- D'Erasmo E, Acca M, Medici F, Pisani D. Clinical aspects of early increase in serum gamma-glutamyl transferase in cerebral infarction. Biomed Pharmacother 1993; 47: 89–92
- Meyer J, Mischeck U, Veyhl M, Henzel K, Galla HJ. Blood-brain barrier characteristic enzymatic properties in cultured brain capillary endothelial cells. Brain Res 1990; 514: 305–9
- Haroon ZA, Wannenburg T, Gupta M, Greenberg CS, Wallin R, Sane DC. Localization of tissue transglutaminase in human carotid and coronary artery atherosclerosis: implications for plaque stability and progression. Lab Invest 2001; 81: 83–93
- Emdin M, Passino C, Michelassi C, Titta F, L'Abbate A, Donato L, et al. Prognostic value of serum gamma-glutamyl transferase activity after myocardial infarction. Eur Heart J 2001; 22: 1802–7
- Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974; 2: 81–5
- Caplan LR. Caplan's stroke: a clinical approach3rd ed. Butterworth-Heinemann, Boston 2000
- Bots ML, Saqlonen JT, Elwood PC, Nikitin Y, Freire de Concalves A, Inzitari D, et al. Gamma-glutamyltransferase and risk of stroke: the Eurostroke Project. J Epidemiol Community Health 2002; 56(Suppl 1)i25–29
- Jousilahti P, Rastenyte D, Tuomilehto J. Serum gamma-glutamyl transferase, self-reported alcohol drinking, and the risk of stroke. Stroke 2002; 33: 1163–4
- Moseley RH. Sepsis and cholestasis. Clinics in liver disease, N Gitlin, DM Jensen. W. B. Saunders, Philadelphia 1999; 465–75
- Lewis JH, Zimmerman HJ. Drug and chemical-induced cholestasis. Clinics in liver disease, N Gitlin, DM Jensen. W. B. Saunders, Philadelphia 1999; 433–64
- Wegmann C, Munzenmaier R, Dormann AJ, Huchzermeyer H. Ticlopidine-induced acute cholestatic hepatitis. Dtsch Med Wochenschr 1998; 123: 146–50
- Cechetto DF. Experimental cerebral ischemic lesions and autonomic and cardiac effects in cats and rats. Stroke 1993; 24(Suppl 12)I6–9
- Oppenheimer SM. Neurogenic cardiac effects of cerebrovascular disease. Curr Opin Neurol 1994; 7: 20–4
- Oppenheimer SM, Hachinski VC. The cardiac consequences of stroke. Neurol Clin 1992; 10: 167–76
- Smith KE, Hachinski VC, Gibson CJ, Ciriello J. Changes in plasma catecholamine levels after insular damage in experimental stroke. Brain Res 1986; 375: 182–5
- Chuttani R, Carr-Locke DL. Motility and dysmotility of the biliary tract and sphincter of Oddi. Gastrointestinal disease5th ed, MH Sleisenger, JS Fordtran, BF Scharshmidt, M Feldman, JP Cello. W. B. Saunders, Philadelphia 1993; 1777–87
- Pitt HA, Doty JE, Roslyn JJ, DenBesten L. The role of altered extrahepatic liver function in the pathogenesis of gallstones after vagotomy. Surgery 1981; 90: 418–25
- Pitt HA, Doty JE, DenBesten L. Increased intra-gallbladder pressure response to cholecystokinin-octapeptide following vagotomy and pyloroplasty. Surg Res 1983; 35: 325–31
- Hutton SW, Sievert CE Jr, Vennes JA, Duane WC. Inhibition of gallstone formation by sphincterectomy in the prairie dog: reversal by atropine. Gastroenterology 1982; 82: 1308–13
- Elta GH. Motility and dysmotility of the biliary tract and sphincter of Oddi. Gastrointestinal and liver disease7th ed, M Feldman, LS Feldman, MH Sleisenger. W. B. Saunders, Philadelphia 2002; 1043–50